Immediate Impact

1 from Science/Nature 12 standout
Sub-graph 1 of 6

Citing Papers

JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship
2023 Standout
2 intermediate papers

Works of Oliver Schmalz being referenced

Digital Monitoring and Management of Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Treated With Cancer Immunotherapy and Its Impact on Quality of Clinical Care: Interview and Survey Study Among Health Care Professionals and Patients
2020
ABVD in Older Patients With Early-Stage Hodgkin Lymphoma Treated Within the German Hodgkin Study Group HD10 and HD11 Trials
2013

Author Peers

Author Last Decade Papers Cites
Oliver Schmalz 15 32 64 74 44 17 159
Francisco Javier Martínez-Peromingo 50 16 34 14 20 23 162
Sarvenaz Shahin 14 15 39 17 8 19 167
Roman Pokora 14 27 14 33 8 16 171
Gülnür Tokuç 4 66 23 27 11 26 160
Lauren Grant 40 15 25 7 37 20 199
B Carstensen 4 34 31 33 10 17 195
Casey Choong 41 4 29 39 16 19 166
Isabelle Guichard 12 65 26 12 9 17 195
Greg Miller 3 20 23 12 17 17 165
Derya Gökçınar 72 12 34 36 35 14 217

All Works

Loading papers...

Rankless by CCL
2026